Merck & Co., Inc. (FRA:6MK)
Germany
· Delayed Price · Currency is EUR 70.10
+0.90 (1.30%)
Last updated: Jun 10, 2025
Merck & Co. Employees
As of December 31, 2024, Merck & Co. had 75,000 total employees, including 73,000 full-time and 2,000 part-time employees. The number of employees increased by 3,000 or 4.17% compared to the previous year.
Employees
75,000
Change (1Y)
3,000
Growth (1Y)
4.17%
Revenue / Employee
€799,198
Profits / Employee
€217,972
Market Cap
175.63B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
| Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
| Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
| Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Siemens Energy AG | 98,000 |
| Siemens Healthineers AG | 72,000 |
Merck & Co. News
- 2 days ago - China’s Center for Drug Evaluation Accepts Merck’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor - Business Upturn
- 2 days ago - FDA approves Mercks RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC
- 2 days ago - US FDA approves Merck's RSV antibody for infants - Reuters
- 2 days ago - U.S. FDA Approves Merck’s ENFLONSIA (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Wallstreet:Online
- 2 days ago - U.S. FDA Approves Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Business Wire
- 2 days ago - Price Over Earnings Overview: Merck & Co - Benzinga
- 2 days ago - Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials - Benzinga
- 2 days ago - Merck succeeds in late-stage trials for cholesterol drug - Seeking Alpha